ArticleFrontiers in pharmacology2023

Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor.

Laura Grohs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.